Treatment of active rheumatoid arthritis: comparison of patients younger vs older than 75 years (CORPUS cohort).

Date publication

septembre 2018

Journal

Human vaccines & immunotherapeutics

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GUILLEMIN Francis

Tous les auteurs :
Oishi S, Wendling D, Sibilia J, Job-Deslandre C, Guillevin L, Benichou J, Flipo RM, Duquenne C, Guillemin F, Saraux A

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/30230962

Résumé

Little information is available on the characteristics of elderly patients starting TNFα antagonist treatment for rheumatoid arthritis (RA). The objective of this work was to compare prescription patterns in RA patients younger vs. older than 75 years.

Mots clés

Rheumatoid arthritis, biologics, elderly, glucocorticoids, prednisone

Référence

Hum Vaccin Immunother. 2018 Sep 19;: